EPO and anemia (phenotype): Unfortunately, in the clinical setting, most cases of acute kidney injury are not identified until some time after renal functional deterioration has occurred and significant anemia emerges several days later [7], decreasing the likelihood that EPO would be administered early in the course of ARF.